title: Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes.
abstract: The xCELLigence real time cell analyzer Cardio system offers a new system for real-time cell analysis that measures impedance-based signals in a label-free noninvasive manner. The aim of this study was to test whether impedance readings are a useful tool to detect compound effects on beating frequency (beats per minute, bpm) and arrhythmias of human induced pluripotent stem cell- and a mouse embryonic stem cell-derived cardiomyocyte line (hiPSC-CM and mESC-CM, respectively). Baseline values for control wells were 45±3 and 179±6 bpm, respectively (n=6). Correspondingly, isoproterenol increased beating frequency by 77% and 71%, whereas carbachol decreased frequency by 11% and 100% (stopped in 5/6 mESC-CM wells). E-4031 decreased beating rate and caused arrhythmias in both cell types, however, more pronounced in the human iPSC-CMs. Amlodipine inhibited contractions in both models, and T-type calcium channel block strongly reduced beating rate and eventually stopped beating in mESC-CM but caused a smaller effect in hiPSC-CM. The results of this initial study show that, under the right conditions, the beating frequency of a monolayer of cells can be stably recorded over several days. Additionally, the system detects changes in beating frequency and amplitude caused by added reference compounds. This assay system has the potential to enable medium-throughput screening, but for implementation into routine daily work, extended validation, testing of additional batches of cardiomyocytes, and further assay optimization (e.g., frequency of media exchange, growth matrix, seeding density, age of cells after plating, and temperature control) will be needed.
authors.affiliation: Department of Medical Physiology, Heart & Lungs Division, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Malin K B
authors.initials: MK
authors.lastname: Jonsson
authors.forename: Qing-Dong
authors.initials: QD
authors.lastname: Wang
authors.forename: Bruno
authors.initials: B
authors.lastname: Becker
mesh_terms: D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D017097:Electric Impedance; D053595:Embryonic Stem Cells / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D051379:Mice; D009200:Myocardial Contraction / Q000187:drug effects* / Q000502:physiology; D032383:Myocytes, Cardiac / Q000187:drug effects* / Q000502:physiology; D039904:Pluripotent Stem Cells / Q000187:drug effects* / Q000502:physiology
chemical_list: D002121:Calcium Channel Blockers; D002316:Cardiotonic Agents
references.citation: Physiol Genomics. 2008 Apr 22;33(2):230-9
references.pmid: 18303085
references.citation: Prog Biophys Mol Biol. 2008 Oct-Nov;98(2-3):328-39
references.pmid: 19038282
references.citation: Cardiovasc Res. 2005 Jan 1;65(1):128-37
references.pmid: 15621040
references.citation: J Pharmacol Toxicol Methods. 2010 May-Jun;61(3):277-86
references.pmid: 20153443
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8259-64
references.pmid: 10393982
references.citation: Nature. 2011 Mar 10;471(7337):225-9
references.pmid: 21240260
references.citation: Stem Cells. 2007 May;25(5):1136-44
references.pmid: 17255522
references.citation: Physiol Rev. 2005 Oct;85(4):1205-53
references.pmid: 16183911
references.citation: Methods Mol Biol. 2011;740:33-43
references.pmid: 21468966
references.citation: Biochem Biophys Res Commun. 2009 Aug 7;385(4):497-502
references.pmid: 19464263
references.citation: Physiol Rev. 2008 Jul;88(3):919-82
references.pmid: 18626064
references.citation: J Pharmacol Sci. 2008 May;107(1):99-102
references.pmid: 18460822
references.citation: Stem Cell Res. 2010 May;4(3):201-13
references.pmid: 20199896
references.citation: J Hum Hypertens. 1991 Aug;5 Suppl 1:49-54
references.pmid: 1834846
references.citation: Expert Opin Drug Discov. 2009 Apr;4(4):357-72
references.pmid: 23485039
references.citation: Expert Opin Investig Drugs. 1997 May;6(5):569-82
references.pmid: 15989621
references.citation: Dent Mater. 2010 Jan;26(1):51-8
references.pmid: 19767088
references.citation: Biochem Soc Trans. 2010 Aug;38(4):1037-45
references.pmid: 20659000
references.citation: Circ Res. 2003 Jul 11;93(1):32-9
references.pmid: 12791707
references.citation: Exp Biol Med (Maywood). 2010 Apr;235(4):522-30
references.pmid: 20407085
references.citation: N Engl J Med. 2010 Oct 7;363(15):1397-409
references.pmid: 20660394
references.citation: Nat Rev Drug Discov. 2004 Aug;3(8):711-5
references.pmid: 15286737
references.citation: J Pharmacol Toxicol Methods. 2009 Jul-Aug;60(1):94-106
references.pmid: 19414070
references.citation: Stem Cell Res. 2010 Mar;4(2):107-16
references.pmid: 20034863
references.citation: Mol Pharmacol. 2006 Apr;69(4):1328-37
references.pmid: 16387796
references.citation: Circulation. 1993 Nov;88(5 Pt 1):2389-401
references.pmid: 8222132
references.citation: Circ Res. 2009 Feb 27;104(4):e30-41
references.pmid: 19213953
references.citation: J Cardiovasc Electrophysiol. 1998 Sep;9(9):934-48
references.pmid: 9786074
references.citation: J Clin Invest. 2010 Dec;120(12):4388-98
references.pmid: 21099118
references.citation: Stem Cell Res. 2010 May;4(3):189-200
references.pmid: 20303332
references.citation: Stem Cells Dev. 2009 Jan-Feb;18(1):161-72
references.pmid: 18510453
references.citation: Anal Chem. 2006 Jan 1;78(1):35-43
references.pmid: 16383308
references.citation: Cell Physiol Biochem. 2010;25(4-5):459-66
references.pmid: 20332627